{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T20:53:13Z","timestamp":1791060793520,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1016\/j.vaccine.2012.12.043","type":"journal-article","created":{"date-parts":[[2012,12,28]],"date-time":"2012-12-28T01:02:04Z","timestamp":1356656524000},"page":"1231-1237","source":"Crossref","is-referenced-by-count":42,"title":["Cell mediated immune response after challenge in Omp25 liposome immunized mice contributes to protection against virulent Brucella abortus 544"],"prefix":"10.1016","volume":"31","author":[{"given":"Divya","family":"Goel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinoth","family":"Rajendran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prahlad C.","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh","family":"Bhatnagar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2012.12.043_bib0005","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1517\/13543784.15.10.1141","article-title":"Future trends in human brucellosis treatment","volume":"15","author":"Pappas","year":"2006","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.vaccine.2012.12.043_bib0010","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1051\/vetres:2005003","article-title":"From the discovery of the Malta fever's agent to the discovery of a marine mammal reservoir, brucellosis has continuously been a re-emerging zoonosis","volume":"36","author":"Godfroid","year":"2005","journal-title":"Vet Res"},{"key":"10.1016\/j.vaccine.2012.12.043_bib0015","first-page":"147","article-title":"Vaccination against Brucella","volume":"13","author":"Nicoletti","year":"1990","journal-title":"Adv Biotechnol Processes"},{"key":"10.1016\/j.vaccine.2012.12.043_bib0020","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1615\/CritRevImmunol.v26.i5.30","article-title":"Host immune responses to the intracellular bacteria Brucella: does the bacteria instruct the host to facilitate chronic infection","volume":"26","author":"Baldwin","year":"2006","journal-title":"Crit Rev Immunol"},{"key":"10.1016\/j.vaccine.2012.12.043_bib0025","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1099\/00222615-43-5-344","article-title":"Outer-membrane protein- and rough lipopolysaccharide-specific monoclonal antibodies protect mice against Brucella ovis","volume":"43","author":"Bowden","year":"1995","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.vaccine.2012.12.043_bib0030","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1099\/00222615-47-1-39","article-title":"Evaluation of immunogenicity and protective activity in BALB\/c mice of the 25-kDa major outer-membrane protein of Brucella melitensis (Omp25) expressed in Escherichia coli","volume":"47","author":"Bowden","year":"1998","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.vaccine.2012.12.043_bib0035","first-page":"367","article-title":"Isolation of three Brucella abortus cell-wall antigens protective in murine experimental brucellosis","volume":"11","author":"Dubray","year":"1980","journal-title":"Ann Rech Vet"},{"key":"10.1016\/j.vaccine.2012.12.043_bib0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1574-6968.1996.tb08547.x","article-title":"Molecular and immunological characterization of the major outer membrane proteins of Brucella","volume":"145","author":"Cloeckaert","year":"1996","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.vaccine.2012.12.043_bib0045","doi-asserted-by":"crossref","first-page":"3945","DOI":"10.1128\/IAI.63.10.3945-3952.1995","article-title":"Surface exposure of outer membrane protein and lipopolysaccharide epitopes in Brucella species studied by enzyme-linked immunosorbent assay and flow cytometry","volume":"63","author":"Bowden","year":"1995","journal-title":"Infect Immun"},{"issue":"Pt. 9","key":"10.1016\/j.vaccine.2012.12.043_bib0050","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1099\/13500872-141-9-2111","article-title":"Restriction site polymorphism of the genes encoding the major 25kDa and 36kDa outer-membrane proteins of Brucella","volume":"141","author":"Cloeckaert","year":"1995","journal-title":"Microbiology"},{"key":"10.1016\/j.vaccine.2012.12.043_bib0055","doi-asserted-by":"crossref","first-page":"4823","DOI":"10.1128\/IAI.69.8.4823-4830.2001","article-title":"Major outer membrane protein Omp25 of Brucella suis is involved in inhibition of tumor necrosis factor alpha production during infection of human macrophages","volume":"69","author":"Jubier-Maurin","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2012.12.043_bib0060","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0378-1135(02)00110-4","article-title":"Brucella species lacking the major outer membrane protein Omp25 are attenuated in mice and protect against Brucella melitensis and Brucella ovis","volume":"88","author":"Edmonds","year":"2002","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2012.12.043_bib0065","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.2460\/ajvr.2001.62.1461","article-title":"Attenuation of a Brucella abortus mutant lacking a major 25kDa outer membrane protein in cattle","volume":"62","author":"Edmonds","year":"2001","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.vaccine.2012.12.043_bib0070","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.vaccine.2006.07.046","article-title":"The identification of two protective DNA vaccines from a panel of five plasmid constructs encoding Brucella melitensis 16M genes","volume":"25","author":"Commander","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.12.043_bib0075","first-page":"458","article-title":"Cytokine production in the murine response to brucella infection or immunization with antigenic extracts","volume":"80","author":"Zhan","year":"1993","journal-title":"Immunology"},{"key":"10.1016\/j.vaccine.2012.12.043_bib0080","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0168-3659(87)90074-5","article-title":"Prolonged delivery of peptides by microcapsules","volume":"6","author":"Maulding","year":"1987","journal-title":"J Control Release"},{"key":"10.1016\/j.vaccine.2012.12.043_bib0085","doi-asserted-by":"crossref","first-page":"3697","DOI":"10.4049\/jimmunol.146.11.3697","article-title":"Universal vaccine carrier. Liposomes that provide T-dependent help to weak antigens","volume":"146","author":"Garcon","year":"1991","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2012.12.043_bib0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0022-1759(91)90120-5","article-title":"Liposomes as carriers of antigens and adjuvants","volume":"140","author":"Alving","year":"1991","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.vaccine.2012.12.043_bib0095","first-page":"229","article-title":"Liposomes as adjuvants with immunopurified tetanus toxoid: influence of liposomal characteristics","volume":"61","author":"Davis","year":"1987","journal-title":"Immunology"},{"key":"10.1016\/j.vaccine.2012.12.043_bib0100","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0022-1759(93)90368-H","article-title":"Liposomes as vaccine carriers. Incorporation of soluble and particulate antigens in giant vesicles","volume":"166","author":"Antimisiaris","year":"1993","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.vaccine.2012.12.043_bib0105","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1017\/S0266462300014033","article-title":"Adjuvants and immune enhancement","volume":"10","author":"Allison","year":"1994","journal-title":"Int J Technol Assess Health Care"},{"key":"10.1016\/j.vaccine.2012.12.043_bib0110","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1017\/S0266462300014045","article-title":"Novel approaches to controlled-release antigen delivery","volume":"10","author":"Cohen","year":"1994","journal-title":"Int J Technol Assess Health Care"},{"key":"10.1016\/j.vaccine.2012.12.043_bib0115","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1006\/immu.1994.1022","article-title":"Liposomes as immunoadjuvants and vaccine carriers: antigen entrapment","volume":"4","author":"Gregoriadis","year":"1994","journal-title":"Immunomethods"},{"key":"10.1016\/j.vaccine.2012.12.043_bib0120","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1006\/meth.1999.0841","article-title":"Vaccine entrapment in liposomes","volume":"19","author":"Gregoriadis","year":"1999","journal-title":"Methods"},{"key":"10.1016\/j.vaccine.2012.12.043_bib0125","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1006\/mpat.1995.0038","article-title":"The Neisseria meningitidis outer membrane protein P1 produced in Bacillus subtilis and reconstituted into phospholipid vesicles elicits antibodies to native P1 epitopes","volume":"18","author":"Muttilainen","year":"1995","journal-title":"Microb Pathog"},{"key":"10.1016\/j.vaccine.2012.12.043_bib0130","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0264-410X(94)90201-1","article-title":"Use of liposome-immunopotentiated exopolysaccharide as a component of an ovine mastitis staphylococcal vaccine","volume":"12","author":"Amorena","year":"1994","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.12.043_bib0135","doi-asserted-by":"crossref","first-page":"3719","DOI":"10.4049\/jimmunol.149.11.3719","article-title":"Intranasal immunization with liposomes containing IL-2 enhances bacterial polysaccharide antigen-specific pulmonary secretory antibody response","volume":"149","author":"Abraham","year":"1992","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2012.12.043_bib0140","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.molimm.2012.02.126","article-title":"Intradermal immunization with outer membrane protein 25 protects Balb\/c mice from virulent B. abortus 544","volume":"51","author":"Goel","year":"2012","journal-title":"Mol Immunol"},{"key":"10.1016\/j.vaccine.2012.12.043_bib0145","doi-asserted-by":"crossref","first-page":"8197","DOI":"10.1128\/JB.01069-08","article-title":"Phosphatidylethanolamine synthesis is required for optimal virulence of Brucella abortus","volume":"190","author":"Bukata","year":"2008","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2012.12.043_bib0150","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1128\/IAI.61.1.124-134.1993","article-title":"Effects of cytokines on intracellular growth of Brucella abortus","volume":"61","author":"Jiang","year":"1993","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2012.12.043_bib0155","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1046\/j.1365-2567.2001.01258.x","article-title":"Interferon-gamma is crucial for surviving a Brucella abortus infection in both resistant C57BL\/6 and susceptible BALB\/c mice","volume":"103","author":"Murphy","year":"2001","journal-title":"Immunology"},{"key":"10.1016\/j.vaccine.2012.12.043_bib0160","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1093\/intimm\/5.8.877","article-title":"Brucella abortus induces a novel cytokine gene expression pattern characterized by elevated IL-10 and IFN-gamma in CD4+ T cells","volume":"5","author":"Svetic","year":"1993","journal-title":"Int Immunol"},{"key":"10.1016\/j.vaccine.2012.12.043_bib0165","doi-asserted-by":"crossref","first-page":"e631","DOI":"10.1371\/journal.pone.0000631","article-title":"Brucella abortus uses a stealthy strategy to avoid activation of the innate immune system during the onset of infection","volume":"2","author":"Barquero-Calvo","year":"2007","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2012.12.043_bib0170","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.4049\/jimmunol.161.3.1447","article-title":"Control of IL-12 and IFN-gamma production in response to live or dead bacteria by TNF and other factors","volume":"161","author":"Zhan","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2012.12.043_bib0175","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1128\/IAI.64.7.2782-2786.1996","article-title":"Tumor necrosis factor alpha and interleukin-12 contribute to resistance to the intracellular bacterium Brucella abortus by different mechanisms","volume":"64","author":"Zhan","year":"1996","journal-title":"Infect Immun"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12018282?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12018282?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T02:52:02Z","timestamp":1687920722000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X12018282"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":35,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["S0264410X12018282"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2012.12.043","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]}}}